Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy (Q33393155)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy |
scientific article |
Statements
1 reference
Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy (English)
1 reference
Robert Jotte
1 reference
Paul Conkling
1 reference
Craig Reynolds
1 reference
Matthew D Galsky
1 reference
Leonard Klein
1 reference
James F Fitzgibbons
1 reference
Richard McNally
1 reference
Markus F Renschler
1 reference
Jennifer W Oliver
1 reference
6 December 2010
1 reference
1 reference
29
1 reference
287-293
1 reference
Identifiers
1 reference
1 reference